JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Prospect of extracellular vesicles in tumor immunotherapy

  • 0Department of Reproductive Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.
Frontiers in Immunology +

|

March 13, 2025

|

March 13, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Extracellular vesicles (EVs) are key to intercellular communication in the tumor microenvironment. This review details their diverse roles in tumor immunotherapy, including cancer vaccines and adoptive cell therapy, and their potential as delivery systems.

Area Of Science

  • Oncology
  • Immunology
  • Biotechnology

Background

  • Extracellular vesicles (EVs) mediate intercellular communication within the tumor microenvironment (TME) by transporting biomolecules.
  • EVs exhibit diverse functions, potentially promoting or inhibiting cancer progression, making their regulation a novel cancer intervention strategy.
  • Advances in EV isolation techniques have increased interest in EV-based therapies for tumor immunotherapy.

Purpose Of The Study

  • To review the multifaceted roles of EVs from various sources in tumor immunotherapy.
  • To highlight the potential of EVs in cancer vaccines and adoptive cell therapy.
  • To explore the application of EVs as nanoparticle delivery systems in cancer treatment.

Main Methods

  • Literature review of studies on extracellular vesicles in tumor immunotherapy.
  • Analysis of EV functions in cancer vaccines, adoptive cell therapy, and drug delivery.
  • Discussion of current clinical applications and future directions for EVs in cancer treatment.

Main Results

  • EVs play significant roles in modulating the TME and influencing cancer progression.
  • EVs show promise as components of cancer vaccines and adoptive cell therapies.
  • EVs can be engineered as effective nanoparticle delivery systems for cancer immunotherapy.

Conclusions

  • EVs offer a promising platform for developing novel cancer immunotherapies.
  • Further research and clinical translation are needed to fully realize the potential of EVs in cancer treatment.
  • Understanding EV biology is crucial for advancing EV-based therapeutic strategies.

Keywords:

Related Concept Videos

Tumor Immunotherapy 01:27

457

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Overview of Exosomes 01:36

2.7K

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Cancer Vaccines 01:30

319

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

The Tumor Microenvironment 02:17

6.5K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...